Please ensure Javascript is enabled for purposes of website accessibility

Vireo Health Fires Bruce Linton

By David Jagielski – Jun 8, 2020 at 10:53PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The former Canopy Growth CEO has been let go from another cannabis company.

Multistate operator Vireo Health (GDNS.F 7.07%) announced on Monday that it was terminating its contract with Executive Chairman Bruce Linton. The former Canopy Growth (CGC 6.29%) CEO joined the U.S. company last November. Vireo doesn't plan to replace Linton and says the termination is "on an entirely without-cause basis, effective immediately."

Linton stated on Monday that "I like the company and pushed it hard, obviously a little too hard for everyone's enjoyment."

In July of last year, Linton was fired as co-CEO of Canopy Growth just days after beer maker Constellation Brands (STZ 2.02%), which invested $4 billion in the pot producer in 2018 , released its quarterly results. Although they were profitable, Constellation's investment in Canopy Growth weighed down the company's per-share earnings by $0.20. 

Office worker packing up personal belongings in a brown box.

Image source: Getty Images.

Executive turnover nothing new for the industry

The cannabis industry's gone through some growing pains over the past few years as many companies have made changes in their upper management. Back in February, Aurora Cannabis (ACB 7.44%) CEO Terry Booth referred to himself as the "latest carnage" after he parted ways with the Canadian pot producer. In January 2019, Aphria (APHA) CEO Vic Neufeld resigned from his position, citing health and family reasons for his decision.

More recently, Cresco Labs (CRLBF 7.83%) co-founder Joe Caltabiano resigned from the Chicago-based pot producer's board after already resigning as president earlier in the year. 

In the past year, pot stocks have taken a beating as the Horizons Marijuana Life Sciences ETF (HMLSF 16.47%) has fallen 57% while the S&P 500 has risen by 11%. 

David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands and Cresco Labs Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Constellation Brands, Inc. Stock Quote
Constellation Brands, Inc.
STZ
$237.43 (2.02%) $4.70
Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.30 (7.44%) $0.09
Canopy Growth Stock Quote
Canopy Growth
CGC
$3.04 (6.29%) $0.18
Horizons Marijuana Life Sciences Index ETF Stock Quote
Horizons Marijuana Life Sciences Index ETF
HMLSF
$4.61 (16.47%) $0.65
Aphria Stock Quote
Aphria
APHA
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$2.63 (7.83%) $0.19
Goodness Growth Holdings, Inc. Stock Quote
Goodness Growth Holdings, Inc.
GDNS.F
$1.00 (7.07%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.